½ÃÀ庸°í¼­
»óǰÄÚµå
1611032

¾È±¸ ÀÓÇöõÆ® ½ÃÀå ±Ô¸ð, Á¡À¯À², µ¿Ç⠺м® º¸°í¼­ : Á¦Ç°º°, ¿ëµµº°, ÃÖÁ¾ ¿ëµµº°, Áö¿ªº°, ºÎ¹®º° ¿¹Ãø(2025-2030³â)

Ocular Implants Market Size, Share & Trends Analysis Report By Product, By Application, By End Use, By Region, And Segment Forecasts, 2025 - 2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Grand View Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® 160 Pages | ¹è¼Û¾È³» : 2-10ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¾È±¸ ÀÓÇöõÆ® ½ÃÀå ¼ºÀå°ú µ¿Çâ:

Grand View Research, Inc.ÀÇ ÃֽŠº¸°í¼­¿¡ µû¸£¸é ¼¼°è ¾È±¸ ÀÓÇöõÆ® ½ÃÀå ±Ô¸ð´Â 2030³â±îÁö 220¾ï 9,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

2025³âºÎÅÍ 2030³â±îÁö ¿¬Æò±Õ 5.8%ÀÇ CAGR·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ±â¼úÀûÀ¸·Î Áøº¸µÈ Á¦Ç° °³¹ß¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁö¸é¼­ ½ÃÀåÀ» °ßÀÎÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¶ÇÇÑ ³ì³»Àå, ¹é³»Àå, ³ëÀμº Ȳ¹Ýº¯¼º µî ¾È°ú ÁúȯÀÇ ¹ßº´·ü Áõ°¡´Â ¾È±¸ ÀÓÇöõÆ® ¼ö¿ä¸¦ ÃËÁøÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¼¼°è³ì³»ÀåÇùȸ¿¡ µû¸£¸é 2020³â¿¡´Â ¾à 7,960¸¸ ¸íÀÌ ³ì³»Àå¿¡ °É¸± °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¸¹Àº ±¹°¡¿¡¼­ ¿©·¯ Â÷·ÊÀÇ ºÀ¼â Á¶Ä¡, ¿©Çà Á¦ÇÑ ¹× Àü¸éÀûÀÎ ºÀ¼â Á¶Ä¡·Î ÀÎÇØ ¼¼°è °æÁ¦´Â Å« ¼Õ½ÇÀ» ÀÔ¾ú°í, °æ±â ħü±â·Î Á¢¾îµé¾úÀ¸¸ç, COVID-19ÀÇ ¿µÇâÀº ÀÇ·á ½Ã½ºÅÛ Àüü¿¡ Å« ¿µÇâÀ» ¹ÌÄ¡°í ÀÖ½À´Ï´Ù. ÀϺΠ½ÃÀå¿¡¼­´Â COVID-19 Áø´Ü ¹× Ä¡·á¿¡ ¾È±¸ ÀÓÇöõÆ®°¡ ÇÊ¿äÇØ ¼ö¿ä°¡ Å©°Ô Áõ°¡ÇÑ ¹Ý¸é, ´Ù¸¥ ½ÃÀå¿¡¼­´Â ƯÈ÷ ÆÒµ¥¹ÍÀÌ ÀýÁ¤¿¡ ´ÞÇßÀ» ¶§ ¸ÅÃâÀÌ ±Þ°¨ÇÏ´Â ¸ð½ÀÀ» º¸¿´½À´Ï´Ù. ÀÌ ½ÃÀåÀº ÈÄÀÚ¿¡ ¼ÓÇϸç, COVID-19 »çÅ·ΠÀÎÇÑ ºÎÁ¤ÀûÀÎ ¿µÇâÀ» ¸ñ°ÝÇß½À´Ï´Ù. Á÷¿ø°ú ȯÀÚ¿¡°Ô ¹ÙÀÌ·¯½º°¡ Àü¿°µÇ´Â °ÍÀ» ÇÇÇϱâ À§ÇØ ¼±ÅÃÀû ¼ö¼úÀÌ Ãë¼ÒµÇ°Å³ª ¿¬±âµÇ¾î 2020³â ¾È±¸ ÀÓÇöõÆ® ÆÇ¸Å °¨¼Ò·Î À̾îÁ³½À´Ï´Ù.

±×·¯³ª ´ëºÎºÐÀÇ ±¹°¡¿¡¼­ Á¦3ÆÄ ¶Ç´Â Á¦4ÆÄÀÇ À¯»çÇÑ ¿µÇâÀ» ¾ïÁ¦Çϱâ À§ÇØ ¹é½Å°ú ÀÌÀü °æÇè¿¡ ±â¹ÝÇÑ Æ¯Á¤ Àü·«À» µµÀÔÇÑ °ÍÀÌ ½ÃÀå ¼ºÀå ȸº¹¿¡ µµ¿òÀÌ µÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, COVID-19 »çÅ·ΠÀÎÇØ ¹ÙÀÌ·¯½º °¨¿° À§ÇèÀÌ ³ôÀº È¥ÀâÇÑ Àå¼Ò¸¦ ÇÇÇϱâ À§ÇØ º´¿øº¸´Ù ¾È°ú Àü¹® ÀÇ·á±â°üÀ» ã´Â ȯÀÚ°¡ Áõ°¡Çϸ鼭 Àü¹® Ŭ¸®´Ð¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, Á÷¾÷ ¹× ±³À° ½Ã½ºÅÛ°ú °ü·ÃµÈ »õ·Î¿î ¿ªÇÐÀº °³ÀÎÀÇ Àüü ½ºÅ©¸° »ç¿ë ½Ã°£À» Áõ°¡½Ã۰í ÀÖÀ¸¸ç, ÀÌ´Â ¾È°ú Áúȯ ¹ß»ý·ü Áõ°¡¿¡ ±â¿©ÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ´Â ¿¹Ãø ±â°£ µ¿¾È ½ÃÀå ¼ºÀåÀ» ÃËÁøÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¾È±¸ ÀÓÇöõÆ® ½ÃÀå º¸°í¼­ ÇÏÀ̶óÀÌÆ®

  • ¼¼°è ³ì³»Àå ¹ßº´·ü Áõ°¡·Î ÀÎÇØ ³ì³»Àå ÀÓÇöõÆ® Á¦Ç° ºÎ¹®ÀÌ 2024³â ½ÃÀåÀ» ÁÖµµÇß½À´Ï´Ù.
  • ³ì³»Àå ¼ö¼ú ¿ëµµ´Â 2024³â¿¡ °¡Àå Å« ¸ÅÃâ Á¡À¯À²À» Â÷ÁöÇßÀ¸¸ç, ÀÌ·¯ÇÑ Ãß¼¼´Â ¿¹Ãø ±â°£ µ¿¾È °è¼ÓµÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
  • ÃÖÁ¾ ¿ëµµº°·Î´Â Àü ¼¼°èÀûÀ¸·Î ÀÔ¿ø ȯÀÚ ¼ö°¡ Áõ°¡ÇÔ¿¡ µû¶ó º´¿ø ºÎ¹®ÀÌ 2024³â 42.29% ÀÌ»óÀÇ ¸ÅÃâ Á¡À¯À²·Î ½ÃÀåÀ» Àå¾ÇÇß½À´Ï´Ù.
  • Àü¹® ¾È°ú ±â°üÀÇ ÃÖÁ¾ ¿ëµµ ºÎ¹®Àº ¿ø°ÝÁö¿¡¼­ ¾È°ú ÀÇ·á ¼­ºñ½º¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÔ¿¡ µû¶ó ¿¹Ãø ±â°£ µ¿¾È Å« ¼ºÀåÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý°ú ¹üÀ§

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ¾È±¸ ÀÓÇöõÆ® ½ÃÀå º¯¼ö, µ¿Çâ, ¹üÀ§

  • ½ÃÀå °èÅë Àü¸Á
    • »óºÎ ½ÃÀå Àü¸Á
    • °ü·Ã/ºÎ¼ö ½ÃÀå Àü¸Á
  • ½ÃÀå ¿ªÇÐ
    • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ ºÐ¼®
    • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ ºÐ¼®
  • ¾È±¸ ÀÓÇöõÆ® ½ÃÀå ºÐ¼® Åø
    • ¾÷°è ºÐ¼® - Porter's Five Forces ºÐ¼®
    • PESTEL ºÐ¼®

Á¦4Àå ¾È±¸ ÀÓÇöõÆ® ½ÃÀå : Á¦Ç° ÃßÁ¤¡¤µ¿Ç⠺м®

  • ºÎ¹® ´ë½Ãº¸µå
  • ¾È±¸ ÀÓÇöõÆ® ½ÃÀå : Á¦Ç° º¯µ¿ ºÐ¼®
  • ¾È±¸ ÀÓÇöõÆ® ½ÃÀå : Á¦Ç°º° Àü¸Á
  • ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø°ú µ¿Ç⠺м®, 2018-2030³â
  • ¾È³» ·»Áî
  • °¢¸· ÀÓÇöõÆ®
  • ¾È¿Í ÀÓÇöõÆ®
  • ³ì³»Àå ÀÓÇöõÆ®
  • Àΰø´«
  • ±âŸ

Á¦5Àå ¾È±¸ ÀÓÇöõÆ® ½ÃÀå : ¿ëµµ ÃßÁ¤¡¤µ¿Ç⠺м®

  • ºÎ¹® ´ë½Ãº¸µå
  • ¾È±¸ ÀÓÇöõÆ® ½ÃÀå : ¿ëµµ º¯µ¿ ºÐ¼®
  • ¾È±¸ ÀÓÇöõÆ® ½ÃÀå : ¿ëµµº° Àü¸Á
  • ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø°ú µ¿Ç⠺м®, 2018-2030³â
  • ³ì³»Àå ¼ö¼ú
  • ´« ¼ºÇü¼ú
  • ¾à¹°Àü´Þ
  • ³ëÀÎȲ¹Ýº¯¼º
  • ¹ÌÀû ¸ñÀû

Á¦6Àå ¾È±¸ ÀÓÇöõÆ® ½ÃÀå : ÃÖÁ¾ ¿ëµµ ÃßÁ¤¡¤µ¿Ç⠺м®

  • ºÎ¹® ´ë½Ãº¸µå
  • ¾È±¸ ÀÓÇöõÆ® ½ÃÀå : ÃÖÁ¾ ¿ëµµ º¯µ¿ ºÐ¼®
  • ¾È±¸ ÀÓÇöõÆ® ½ÃÀå : ÃÖÁ¾ ¿ëµµº° Àü¸Á
  • ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø°ú µ¿Ç⠺м®, 2018-2030³â
  • º´¿ø
  • Àü¹® ¾È°ú
  • Ŭ¸®´Ð

Á¦7Àå ¾È±¸ ÀÓÇöõÆ® ½ÃÀå : Áö¿ª ÃßÁ¤¡¤µ¿Ç⠺м®

  • Áö¿ª ´ë½Ãº¸µå
  • Áö¿ªº° ¾È±¸ ÀÓÇöõÆ® ½ÃÀå º¯µ¿ ºÐ¼®
  • ¾È±¸ ÀÓÇöõÆ® ½ÃÀå : Á¦Ç°º°, ¿ëµµº°, ÃÖÁ¾ ¿ëµµº° Áö¿ª ÃßÁ¤¡¤µ¿Ç⠺м®
  • ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø°ú µ¿Ç⠺м®, 2018-2030³â
  • ºÏ¹Ì
    • ¹Ì±¹
    • ij³ª´Ù
    • ¸ß½ÃÄÚ
    • À¯·´
    • ¿µ±¹
    • µ¶ÀÏ
    • ÇÁ¶û½º
    • ÀÌÅ»¸®¾Æ
    • ½ºÆäÀÎ
    • µ§¸¶Å©
    • ½º¿þµ§
    • ³ë¸£¿þÀÌ
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • ÀϺ»
    • Áß±¹
    • Àεµ
    • Çѱ¹
    • È£ÁÖ
    • ű¹
  • ¶óƾ¾Æ¸Þ¸®Ä«
    • ºê¶óÁú
    • ¾Æ¸£ÇîÆ¼³ª
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ¾Æ¶ø¿¡¹Ì¸®Æ®
    • Äí¿þÀÌÆ®

Á¦8Àå °æÀï ±¸µµ

  • ½ÃÀå ÁøÃâ ±â¾÷ ºÐ·ù
  • ÁÖ¿ä ±â¾÷ °³¿ä
    • Alcon, Inc.
    • Bausch + Lomb.
    • Carl Zeiss AG
    • Johnson & Johnson Services, Inc.
    • STAAR SURGICAL
    • MORCHER GmbH
    • Glaukos Corporation.
ksm 24.12.30

Ocular Implants Market Growth & Trends:

The global ocular implants market size is expected to reach USD 22.09 billion by 2030, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 5.8% from 2025 to 2030. Increasing focus on the development of technologically advanced products is expected to drive the market. Additionally, the growing incidence of eye disorders such as glaucoma, cataract, and age-related macular degeneration is predicted to propel the demand for ocular implants. According to the World Glaucoma Association, an estimated 79.6 million individuals were anticipated to have glaucoma in 2020.

Due to the imposition of multiple lockdown restrictions, travel restrictions, and complete lockdowns in many countries, the economies worldwide have observed a major loss moving it into a state of recession. The COVID-19 impact was also strongly felt across the healthcare systems. While certain markets witnessed a major rise in demand due to the need for ocular implants in diagnoses and the treatment of COVID-19, certain other products observed a sharp fall in sales, especially during the peak of the pandemic. The market belonged to the latter and witnessed a negative impact due to the outbreak of COVID-19. The cancellation and postponement of elective surgeries in order to avoid the transmission of the virus to the staff and patients led to a fall in the sales of ocular implants in 2020.

However, the introduction of vaccines and specific strategies based on earlier experience to curtail the similar impact of the third or fourth wave in most countries is helping the market to regain its growth. Additionally, the outbreak of COVID-19 has created a higher preference among patients to visit specialty eye institutes rather than hospitals in order to avoid crowded places that pose a higher threat of contracting the virus, thereby increasing the demand for specialty clinics. Moreover, the new dynamics involved in the occupation and education system have increased the overall screen-time of individuals, which is expected to contribute to the rising incidence of eye diseases. This, in turn, is expected to enhance the market growth during the forecast period.

Ocular Implants Market Report Highlights:

  • The glaucoma implants product segment dominated the market in 2024 owing to the growing incidence of glaucoma globally
  • The glaucoma surgery application held the largest revenue share in 2024 and this trend is expected to continue during the forecast period
  • By end use, the hospitals segment dominated the market with a revenue share of more than 42.29% in 2024 due to the increasing number of hospital admissions across the globe
  • The specialty eye institutes end-use segment is expected to witness significant growth during the forecast period owing to the rising need for eye care services in remote areas

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. Application
    • 1.2.3. End-Use
    • 1.2.4. Regional scope
    • 1.2.5. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
      • 1.4.5.1. Data for primary interviews in North America
      • 1.4.5.2. Data for primary interviews in Europe
      • 1.4.5.3. Data for primary interviews in Asia Pacific
      • 1.4.5.4. Data for primary interviews in Latin America
      • 1.4.5.5. Data for Primary interviews in MEA
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
    • 2.2.2. Application outlook
    • 2.2.3. End Use outlook
  • 2.3. Regional outlook
  • 2.4. Competitive Insights

Chapter 3. Ocular Implants Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Increasing incidence of eye disorders
      • 3.2.1.2. Growing geriatric and diabetic population
      • 3.2.1.3. Technological advancements
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Recent product recalls
  • 3.3. Ocular Implants Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Bargaining power of suppliers
      • 3.3.1.2. Bargaining power of buyers
      • 3.3.1.3. Threat of substitutes
      • 3.3.1.4. Threat of new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic landscape
      • 3.3.2.3. Social landscape
      • 3.3.2.4. Technological landscape
      • 3.3.2.5. Environmental landscape
      • 3.3.2.6. Legal landscape

Chapter 4. Ocular Implants Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Ocular Implants Market: Product Movement Analysis
  • 4.3. Ocular Implants Market by Product Outlook (USD Million)
  • 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 4.5. Intraocular Lens
    • 4.5.1. Intraocular Lens Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6. Corneal Implants
    • 4.6.1. Corneal Implants Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.7. Orbital Implants
    • 4.7.1. Orbital Implants Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.8. Glaucoma Implants
    • 4.8.1. Glaucoma Implants Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.9. Ocular Prosthesis
    • 4.9.1. Ocular Prosthesis Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.10. Others
    • 4.10.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Ocular Implants Market: Application Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Ocular Implants Market: Application Movement Analysis
  • 5.3. Ocular Implants Market by Application Outlook (USD Million)
  • 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 5.5. Glaucoma Surgery
    • 5.5.1. Glaucoma Surgery Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Oculoplasty
    • 5.6.1. Oculoplasty Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.7. Drug Delivery
    • 5.7.1. Drug Delivery Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.8. Age related Macular Degeneration
    • 5.8.1. Age related Macular Degeneration Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.9. Aesthetic Purpose
    • 5.9.1. Aesthetic Purpose Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Ocular Implants Market: End Use Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Ocular Implants Market: End Use Movement Analysis
  • 6.3. Ocular Implants Market by End Use Outlook (USD Million)
  • 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 6.5. Hospitals
    • 6.5.1. Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Specialty Eye institutes
    • 6.6.1. Specialty Eye Institutes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.7. Clinics
    • 6.7.1. Clinics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Ocular Implants Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Dashboard
  • 7.2. Regional Ocular Implants Market movement analysis
  • 7.3. Ocular Implants Market: Regional Estimates & Trend Analysis by Product, Application & End-use
  • 7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 7.5. North America
    • 7.5.1. North America Ocular Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.2. U.S.
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Competitive Scenario
      • 7.5.2.3. Regulatory Framework
      • 7.5.2.4. Reimbursement scenario
      • 7.5.2.5. U.S. Ocular Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.3. Canada
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Competitive Scenario
      • 7.5.3.3. Regulatory Framework
      • 7.5.3.4. Reimbursement scenario
      • 7.5.3.5. Canada Ocular Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.4. Mexico
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Competitive Scenario
      • 7.5.4.3. Regulatory Framework
      • 7.5.4.4. Reimbursement scenario
      • 7.5.4.5. Mexico Ocular Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.5. Europe
    • 7.5.6. Europe Ocular Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.7. UK
      • 7.5.7.1. Key Country Dynamics
      • 7.5.7.2. Competitive Scenario
      • 7.5.7.3. Regulatory Framework
      • 7.5.7.4. Reimbursement scenario
      • 7.5.7.5. UK Ocular Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.8. Germany
      • 7.5.8.1. Key Country Dynamics
      • 7.5.8.2. Competitive Scenario
      • 7.5.8.3. Regulatory Framework
      • 7.5.8.4. Reimbursement scenario
      • 7.5.8.5. Germany Ocular Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.9. France
      • 7.5.9.1. Key Country Dynamics
      • 7.5.9.2. Competitive Scenario
      • 7.5.9.3. Regulatory Framework
      • 7.5.9.4. Reimbursement scenario
      • 7.5.9.5. France Ocular Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.10. Italy
      • 7.5.10.1. Key Country Dynamics
      • 7.5.10.2. Competitive Scenario
      • 7.5.10.3. Regulatory Framework
      • 7.5.10.4. Reimbursement scenario
      • 7.5.10.5. Italy Ocular Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.11. Spain
      • 7.5.11.1. Key Country Dynamics
      • 7.5.11.2. Competitive Scenario
      • 7.5.11.3. Regulatory Framework
      • 7.5.11.4. Reimbursement scenario
      • 7.5.11.5. Spain Ocular Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.12. Denmark
      • 7.5.12.1. Key Country Dynamics
      • 7.5.12.2. Competitive Scenario
      • 7.5.12.3. Regulatory Framework
      • 7.5.12.4. Reimbursement scenario
      • 7.5.12.5. Denmark Ocular Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.13. Sweden
      • 7.5.13.1. Key Country Dynamics
      • 7.5.13.2. Competitive Scenario
      • 7.5.13.3. Regulatory Framework
      • 7.5.13.4. Reimbursement scenario
      • 7.5.13.5. Sweden Ocular Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.14. Norway
      • 7.5.14.1. Key Country Dynamics
      • 7.5.14.2. Competitive Scenario
      • 7.5.14.3. Regulatory Framework
      • 7.5.14.4. Reimbursement scenario
      • 7.5.14.5. Norway Ocular Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6. Asia Pacific
    • 7.6.1. Asia Pacific Ocular Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.2. Japan
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Competitive Scenario
      • 7.6.2.3. Regulatory Framework
      • 7.6.2.4. Reimbursement scenario
      • 7.6.2.5. Japan Ocular Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.3. China
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Competitive Scenario
      • 7.6.3.3. Regulatory Framework
      • 7.6.3.4. Reimbursement scenario
      • 7.6.3.5. China Ocular Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.4. India
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Competitive Scenario
      • 7.6.4.3. Regulatory Framework
      • 7.6.4.4. Reimbursement scenario
      • 7.6.4.5. India Ocular Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.5. South Korea
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Competitive Scenario
      • 7.6.5.3. Regulatory Framework
      • 7.6.5.4. Reimbursement scenario
      • 7.6.5.5. South Korea Ocular Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.6. Australia
      • 7.6.6.1. Key Country Dynamics
      • 7.6.6.2. Competitive Scenario
      • 7.6.6.3. Regulatory Framework
      • 7.6.6.4. Reimbursement scenario
      • 7.6.6.5. Australia Ocular Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.7. Thailand
      • 7.6.7.1. Key Country Dynamics
      • 7.6.7.2. Competitive Scenario
      • 7.6.7.3. Regulatory Framework
      • 7.6.7.4. Reimbursement scenario
      • 7.6.7.5. Thailand Ocular Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.7. Latin America
    • 7.7.1. Latin America Ocular Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.7.2. Brazil
      • 7.7.2.1. Key Country Dynamics
      • 7.7.2.2. Competitive Scenario
      • 7.7.2.3. Regulatory Framework
      • 7.7.2.4. Reimbursement scenario
      • 7.7.2.5. Brazil Ocular Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.7.3. Argentina
      • 7.7.3.1. Key Country Dynamics
      • 7.7.3.2. Competitive Scenario
      • 7.7.3.3. Regulatory Framework
      • 7.7.3.4. Reimbursement scenario
      • 7.7.3.5. Argentina Ocular Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.8. Middle East & Africa
    • 7.8.1. Middle East & Africa Ocular Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.8.2. South Africa
      • 7.8.2.1. Key Country Dynamics
      • 7.8.2.2. Competitive Scenario
      • 7.8.2.3. Regulatory Framework
      • 7.8.2.4. Reimbursement scenario
      • 7.8.2.5. South Africa Ocular Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.8.3. Saudi Arabia
      • 7.8.3.1. Key Country Dynamics
      • 7.8.3.2. Competitive Scenario
      • 7.8.3.3. Regulatory Framework
      • 7.8.3.4. Reimbursement scenario
      • 7.8.3.5. Saudi Arabia Ocular Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.8.4. UAE
      • 7.8.4.1. Key Country Dynamics
      • 7.8.4.2. Competitive Scenario
      • 7.8.4.3. Regulatory Framework
      • 7.8.4.4. Reimbursement scenario
      • 7.8.4.5. UAE Ocular Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.8.5. Kuwait
      • 7.8.5.1. Key Country Dynamics
      • 7.8.5.2. Competitive Scenario
      • 7.8.5.3. Regulatory Framework
      • 7.8.5.4. Reimbursement scenario
      • 7.8.5.5. Kuwait Ocular Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Market Participant Categorization
  • 8.2. Key Company Profiles
    • 8.2.1. Alcon, Inc.
      • 8.2.1.1. Company overview
      • 8.2.1.2. Financial performance
      • 8.2.1.3. Product benchmarking
      • 8.2.1.4. Strategic initiatives
    • 8.2.2. Bausch + Lomb.
      • 8.2.2.1. Company overview
      • 8.2.2.2. Financial performance
      • 8.2.2.3. Product benchmarking
      • 8.2.2.4. Strategic initiatives
    • 8.2.3. Carl Zeiss AG
      • 8.2.3.1. Company overview
      • 8.2.3.2. Financial performance
      • 8.2.3.3. Product benchmarking
      • 8.2.3.4. Strategic initiatives
    • 8.2.4. Johnson & Johnson Services, Inc.
      • 8.2.4.1. Company overview
      • 8.2.4.2. Financial performance
      • 8.2.4.3. Product benchmarking
      • 8.2.4.4. Strategic initiatives
    • 8.2.5. STAAR SURGICAL
      • 8.2.5.1. Company overview
      • 8.2.5.2. Financial performance
      • 8.2.5.3. Product benchmarking
      • 8.2.5.4. Strategic initiatives
    • 8.2.6. MORCHER GmbH
      • 8.2.6.1. Company overview
      • 8.2.6.2. Financial performance
      • 8.2.6.3. Product benchmarking
      • 8.2.6.4. Strategic initiatives
    • 8.2.7. Glaukos Corporation.
      • 8.2.7.1. Company overview
      • 8.2.7.2. Financial performance
      • 8.2.7.3. Product benchmarking
      • 8.2.7.4. Strategic initiatives
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦